Insulin in aging and cancer: antidiabetic drug diabenol as geroprotector and anticarcinogen
- 31 May 2005
- journal article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 37 (5) , 1117-1129
- https://doi.org/10.1016/j.biocel.2004.08.002
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 DeacetylaseScience, 2004
- Insulin/IGF-1 signaling pathway driving aging and cancer as a target for pharmacological intervention.Experimental Gerontology, 2003
- Insulin-like growth factor 1 (IGF-1) and aging: Controversies and new insightsBiogerontology, 2003
- Insulin and longevity: antidiabetic biguanides as geroprotectorsBiogerontology, 2003
- Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER‐2/neu transgenic miceInternational Journal of Cancer, 2002
- Metformin and Polycystic Ovary Syndrome: A Literature ReviewJournal of Obstetrics and Gynaecology Canada, 2002
- Spontaneous tumors in NMRI mice from carcinogenicity studiesExperimental pathology, 1989
- Effect of anticarcinogens on the transplacental carcinogenic effect of N-nitroso-N-ethylureaBulletin of Experimental Biology and Medicine, 1985
- The inhibition of the transplacental blastomogenic effect of nitrosomethylurea by postnatal administration of buformin to ratsCarcinogenesis: Integrative Cancer Research, 1980
- Inhibition of the carcinogenic effect of 7,12-dimethylbenz(a)anthracene in female rats by buformin, phenytoin, pineal polypeptide extract, and L-dopaBulletin of Experimental Biology and Medicine, 1980